Dual Sensitization Anti-Resistant Nanoparticles for Treating Refractory Breast Cancers via Apoptosis-Inducing

References

• Fahad Ullah M. Breast cancer: current perspectives on the disease status. Adv Exp Med Biol. 2019;1152:51–64. doi:10.1007/978-3-030-20301-6_4
   PubMed Web of Science ®Google Scholar
• Kim MY. Breast cancer metastasis. Adv Exp Med Biol. 2021;1187:183–204. doi:10.1007/978-981-32-9620-6_9
   PubMed Web of Science ®Google Scholar
• Nedeljković M, Damjanović A. Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge. Cells. 2019;8(9):957. doi:10.3390/cells8090957
   PubMed Web of Science ®Google Scholar
• Gote V, Nookala AR, Bolla PK, Pal D. Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue. Int J Mol Sci. 2021;22(9):4673. doi:10.3390/ijms22094673
   PubMed Web of Science ®Google Scholar
• Wu Q, Yang Z, Nie Y, Shi Y, Fan D. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett. 2014;347(2):159–166. doi:10.1016/j.canlet.2014.03.013
   PubMed Web of Science ®Google Scholar
• Kartal-Yandim M, Adan-Gokbulut A, Baran Y. Molecular mechanisms of drug resistance and its reversal in cancer. Crit Rev Biotechnol. 2016;36(4):716–726. doi:10.3109/07388551.2015.1015957
   PubMed Web of Science ®Google Scholar
• Zheng HC. The molecular mechanisms of chemoresistance in cancers. Oncotarget. 2017;8(35):59950–59964. doi:10.18632/oncotarget.19048
   PubMedGoogle Scholar
• Champeau M, Vignoud S, Mortier L, Mordon S. Photodynamic therapy for skin cancer: how to enhance drug penetration? J Photochem Photobiol B. 2019;197:111544. doi:10.1016/j.jconrel.2016.06.017
   PubMed Web of Science ®Google Scholar
• Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3(5):380–387. doi:10.1038/nrc1071
   PubMed Web of Science ®Google Scholar
• Kumari P, Paul M, Bhatt H, et al. Chlorin e6 Conjugated Methoxy-Poly(Ethylene Glycol)-Poly(D,L-Lactide) Glutathione Sensitive Micelles for Photodynamic Therapy. Pharm Res. 2020;37(2):18. doi:10.1007/s11095-019-2750-0
   PubMed Web of Science ®Google Scholar
• Jalde SS, Chauhan AK, Lee JH, Chaturvedi PK, Park JS, Kim YW. Synthesis of novel Chlorin e6-curcumin conjugates as photosensitizers for photodynamic therapy against pancreatic carcinoma. Eur J Med Chem. 2018;147:66–76. doi:10.1016/j.ejmech.2018.01.099
   PubMed Web of Science ®Google Scholar
• Shanmugam V, Selvakumar S, Yeh CS. Near-infrared light-responsive nanomaterials in cancer therapeutics. Chem Soc Rev. 2014;43(17):6254–6287. doi:10.1039/c4cs00011k
   PubMed Web of Science ®Google Scholar
• Choudhury H, Gorain B, Pandey M, et al. Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. Int J Pharm. 2017;529(1–2):506–522. doi:10.1016/j.ijpharm.2017.07.018
   PubMed Web of Science ®Google Scholar
• Yan H, Du X, Wang R, Zhai G. Progress in the study of D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) reversing multidrug resistance. Colloids Surf B Biointerfaces. 2021;205:111914. doi:10.1016/j.colsurfb.2021.111914
   PubMed Web of Science ®Google Scholar
• Bayer IS. Hyaluronic Acid and Controlled Release: a Review. Molecules. 2020;25(11):2649. doi:10.3390/molecules25112649
   PubMed Web of Science ®Google Scholar
• Abatangelo G, Vindigni V, Avruscio G, Pandis L, Brun P. Hyaluronic Acid: redefining Its Role. Cells. 2020;9(7):1743. doi:10.3390/cells9071743
   PubMed Web of Science ®Google Scholar
• Rezaei S, Kashanian S, Bahrami Y, Cruz LJ, Motiei M. Redox-Sensitive and Hyaluronic Acid-Functionalized Nanoparticles for Improving Breast Cancer Treatment by Cytoplasmic 17α-Methyltestosterone Delivery. Molecules. 2020;25(5):5. doi:10.3390/molecules25051181
   Web of Science ®Google Scholar
• Bernabeu E, Cagel M, Lagomarsino E, Moretton M, Chiappetta DA. Paclitaxel: what has been done and the challenges remain ahead. Int J Pharm. 2017;526(1–2):474–495. doi:10.1016/j.ijpharm.2017.05.016
   PubMed Web of Science ®Google Scholar
• Sofias AM, Dunne M, Storm G, Allen C. The battle of “nano” paclitaxel. Adv Drug Deliv Rev. 2017;122:20–30. doi:10.1016/j.addr.2017.02.003
   PubMed Web of Science ®Google Scholar
• Haggag Y, Abu Ras B, El-Tanani Y, et al. Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells. Expert Opin Drug Deliv. 2020;17(11):1655–1669. doi:10.1080/17425247.2020.1813714
   PubMed Web of Science ®Google Scholar
• Haggag YA, Yasser M, Tambuwala MM, El Tokhy SS, Isreb M, Donia AA. Repurposing of Guanabenz acetate by encapsulation into long-circulating nanopolymersomes for treatment of triple-negative breast cancer. Int J Pharm. 2021;600:120532. doi:10.1016/j.ijpharm.2021.120532
   PubMed Web of Science ®Google Scholar
• Haggag YA, Abosalha AK, Tambuwala MM, et al. Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity. Biopharm Drug Dispos. 2021;42(1):12–23. doi:10.1002/bdd.2255
   PubMed Web of Science ®Google Scholar
• Hurwitz M. Chemotherapy in Prostate Cancer. Curr Oncol Rep. 2015;17(10):44. doi:10.1007/s11912-015-0468-7
   PubMed Web of Science ®Google Scholar
• Kim JH. Chemotherapy for colorectal cancer in the elderly. World J Gastroenterol. 2015;21(17):5158–5166. doi:10.3748/wjg.v21.i17.5158
   PubMed Web of Science ®Google Scholar
• Marsh S, Liu G. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy. Adv Drug Deliv Rev. 2009;61(5):381–387. doi:10.1016/j.addr.2008.10.003
   PubMed Web of Science ®Google Scholar
• Roett MA, Evans P. Ovarian cancer: an overview. Am Fam Physician. 2009;80(6):609–616.
   PubMed Web of Science ®Google Scholar
• Bukowski K, Kciuk M, Kontek R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int J Mol Sci. 2020;21(9):3233. doi:10.3390/ijms21093233
   PubMed Web of Science ®Google Scholar
• Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5(3):219–234. doi:10.1038/nrd1984
   PubMed Web of Science ®Google Scholar
• Liu X. ABC Family Transporters. Adv Exp Med Biol. 2019;1141:13–100. doi:10.1007/978-981-13-7647-4_2
   PubMed Web of Science ®Google Scholar
• Choi YH, Yu AM. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Curr Pharm Des. 2014;20(5):793–807. doi:10.2174/138161282005140214165212
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65(1–2):271–284. doi:10.1016/s0168-3659(99)
   PubMed Web of Science ®Google Scholar
• Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP. Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. J Personalized Med. 2021;11(6):Jun. doi:10.3390/jpm11060571
   Web of Science ®Google Scholar
• Bao J, Zhang Q, Duan T, Hu R, Tang J. The fate of nanoparticles in vivo and the strategy of designing stealth nanoparticle for drug delivery. Curr Drug Targets. 2021;22(8):922–946. doi:10.2174/1389450122666210118105122
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B, Cheng G, Hardy M, et al. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: therapeutic targeting of tumor mitochondria with lipophilic cationic compounds. Redox Biol. 2018;14:316–327. doi:10.1016/j.redox.2017.09.020
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S. DLS and zeta potential - What they are and what they are not? J Controlled Release. 2016;235:337–351. doi:10.1016/j.jconrel.2016.06.017
   PubMed Web of Science ®Google Scholar
• Gabizon A, Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs. 1997;54(Suppl 4):15–21. doi:10.2165/00003495-199700544-00005
   PubMed Web of Science ®Google Scholar
• Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine. 2014;9(Suppl1):51–63. doi:10.2147/ijn.s26592
   PubMedGoogle Scholar
• Crowley LC, Marfell BJ, Scott AP, Waterhouse NJ. Quantitation of apoptosis and necrosis by annexin v binding, propidium iodide uptake, and flow cytometry. Cold Spring Harb Protoc. 2016;2016(11):548. doi:10.1101/pdb.prot087288
   Google Scholar
• Tengku Din TA, Seeni A, Khairi WN, Shamsuddin S, Jaafar H. Effects of rapamycin on cell apoptosis in MCF-7 human breast cancer cells. Asian Pacific J Cancer Prevention. 2014;15(24):10659–10663. doi:10.7314/apjcp.2014.15.24.10659
   PubMedGoogle Scholar
• Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell. 2002;9(3):459–470. doi:10.1016/s1097-2765(02)
   PubMed Web of Science ®Google Scholar
• Bruckheimer EM, Cho SH, Sarkiss M, Herrmann J, McDonnell TJ. The Bcl-2 gene family and apoptosis. Adv Biochem Eng Biotechnol. 1998;62:75–105. doi:10.1007/BFb0102306
   PubMedGoogle Scholar
• Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol. 2008;9(7):532–542. doi:10.1038/nrm2434
   PubMed Web of Science ®Google Scholar